TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Blueprint for EECA countries, first edition
HIV Treatment
Policy Brief
July 2017
Key populations brief
Accessed 2017
Suggested language and usage for tuberculosis communications
First edition
Accessed November 2017
Key populations brief
Accessed November 2017
Lessons from the STEP-TB Project.
Accessed November 2017.
A compendium of TB REACH case studies, lessons learned and a monitoring and evaluation framework.
Accessed November 2017.
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.14
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.11
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more